RIPK1 and cancer: For instance, while multiple studies have indeed found that, whole tumor-biopsy level, high expression of RIPK3 or even sometimes MLKL may predict prolonged cancer patient survival (Table 3), yet high expression of RIPK1 or MLKL has also been documented to predict worse prognosis for some cancer patients (Table 3).